Asia stocks rise, spurred by hopes for COVID-19 treatment | Inquirer Business

Asia stocks rise, spurred by hopes for COVID-19 treatment

/ 06:17 PM August 25, 2020

Japan Financial Markets

A woman walks past an electronic stock board showing Japan’s Nikkei 225 index at a securities firm in Tokyo Monday, Aug. 24, 2020. Asian stock markets rose Monday after Wall Street hit a new high despite lingering unease about a possible second wave of coronavirus infections. (AP Photo/Eugene Hoshiko)

TOKYO— Asian shares were mostly higher Tuesday as investors hung onto hopes the coronavirus pandemic may come under control as treatments get developed.

“The positive coverage on potential COVID-19 vaccines and treatments opens the door wide open to a rotating carousel of stocks,” said Stephen Innes, chief global markets strategist at AxiCorp.


If symptoms of the infection could become as mild as a cough or runny nose during a flu, the economy could return to normal, he added.


Japan’s benchmark Nikkei 225 index rose 1.7% to 23,378.47. South Korea’s Kospi gained 1.5% to 2,364.25. Australia’s S&P/ASX 200 added 0.5% to 6,159.60. Hong Kong’s Hang Seng edged down 0.2% to 25,498.77, while the Shanghai Composite was up 0.2% at 3,392.49.

Investors are also awaiting a speech by U.S. Federal Reserve Chair Jerome Powell later this week that he would normally give at Jackson Hole, Wyoming. This year’s economic policy symposium will be online due to the pandemic.

Investors closely follow speeches at the annual Jackson Hole event, where Fed officials sometimes generate market-moving headlines. This year’s event is titled “Navigating the Decade Ahead: Implications for Monetary Policy.”

While signs that the increase in COVID-19 cases around the world may be slowing down gradually are cause for optimism, worries about recurring waves remain.

“The news that a Hong Kong man has been proven to be reinfected with COVID-19 means that the assumption of the market that it is only a matter of time before a vaccine comes and brings back the old life again, is more questionable,” said Robert Carnell, regional head of research, Asia Pacific, at ING.

“But perhaps we should be tempering our optimism,” he said.


On Wall Street, the S&P 500 rallied 1% to 3,431.28 and added to the all-time high it set last week. The Dow Jones Industrial Average rose 1.4% to 28,308.46, and the Nasdaq composite added 0.6% to 11,379.72.

Pharmaceutical companies working toward a possible vaccine for COVID-19 is helping invigorate shares of industries that have been beaten by the pandemic. Airlines climbed, for example, amid the possibility that people may feel safe enough to travel again in the future. Delta Air Lines rose 9.3%, and American Airlines Group added 10.5%.

One winner of the new normal, Zoom Video Communications, stumbled. Its shares fell 2.6% after it reported partial outages in its Zoom Meetings service, which has become the default way for classrooms and businesses around the world to communicate. By midday on the East Coast, it said it had resolved the issue.

Also Monday, it was announced that some big names in the Dow Jones Industrial Average are slated to be dropped from the 30-company index. Exxon Mobil, Pfizer and Raytheon Technologies will be replaced before trading opens next Monday by, Amgen and Honeywell International.

Benchmark U.S. crude oil slipped 5 cents to $42.57 a barrel in electronic trading on the New York Mercantile Exchange. It rose 28 cents to $42.62 per barrel Monday. Brent crude, the international standard, rose 11 cents to $45.24 a barrel.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The dollar inched up to 105.90 Japanese yen from 105.82 yen. The euro cost $1.1805, down from $1.1817.

TAGS: Business, COVID-19 vaccines, Nikkei, Stock Market, Wall Street, world

© Copyright 1997-2024 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.